Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Regional Innovation in Chronic Disease and Elderly Care

26. maj 2026 opdateret af: Ke-Yun, Chao, Fu Jen Catholic University

A Regional Integrated Care Innovation Program for Cardiometabolic Health, Pulmonary-Circulatory Disease Management, and Elderly Support

This project aims to develop a community-based health promotion intervention model for populations at potential risk of metabolic syndrome. Through exercise training and lifestyle modifications, the project seeks to improve cardiopulmonary function and disease control, align with current public health policies, and establish an evidence-based model with strong potential for broader implementation.

Studieoversigt

Detaljeret beskrivelse

Background: Hypertension, diabetes, and dyslipidemia are major risk factors for cardiovascular disease, with prevalence continuing to rise in Taiwan. These conditions are closely associated with shared risk factors such as aging, obesity, and smoking. The districts of Xinzhuang, Wugu, and Taishan in New Taipei City are densely populated and have a significant aging population. Environmental changes such as urbanization and air pollution pose threats to residents' cardiopulmonary health. Exercise interventions have been proven effective in improving blood pressure, blood glucose, and lipid profiles, as well as enhancing cardiopulmonary function and quality of life. Therefore, implementing structured and personalized exercise promotion programs in the community is of great importance for disease control and health promotion among populations with metabolic syndrome.

Methods: Participants will first undergo a one-month in-hospital conventional exercise training program, followed by an eleven-month home-based exercise intervention. During and after the intervention period, physical activity assessments and biochemical blood tests will be conducted.

Effect: This project aims to establish a community-based health promotion model for individuals at risk of hypertension, diabetes, and hyperlipidemia, centered on exercise interventions and lifestyle modifications. Through assessment, stratification, intervention, and outcome tracking, the project seeks to enhance health behaviors, self-management skills, and cardiopulmonary function in at-risk populations, thereby slowing disease progression and reducing healthcare resource utilization. The research findings will be submitted to relevant domestic and international academic conferences and SCI journals to increase Taiwan's international visibility in the fields of geriatric and "three highs" care. Additionally, the project will cultivate a new generation of healthcare professionals equipped with practical skills in preventive medicine and health promotion, strengthening interprofessional teamwork and community outreach capacity.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

1000

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

      • New Taipei City, Taiwan, 24352
        • Rekruttering
        • Fu Jen Catholic University Hospital, Fu Jen Catholic University
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

patient of Affiliated University Hospital

Beskrivelse

Inclusion Criteria:

  • Participants with hypertension, hyperglycemia, or hyperlipidemia who meet at least one of these criteria are eligible for enrollment.

Exclusion Criteria:

  • Age under 18 years
  • Patients diagnosed with neuromuscular disorders
  • Inability to perform cardiopulmonary exercise testing
  • Refusal to participate in the study

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
appendicular skeletal muscle mass index
Tidsramme: From enrollment to the end of intervention at 12 months
appendicular skeletal muscle mass (ASM) divided by height squared; low muscle mass is defined as ASMI < 7.0 kg/m² in men and < 5.7 kg/m² in women
From enrollment to the end of intervention at 12 months
six minute walk test
Tidsramme: From enrollment to the end of intervention at 12 months
functional performance; higher scores mean a better outcome
From enrollment to the end of intervention at 12 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Ke-Yun Chao, PhD, Fu Jen Catholic University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

26. maj 2026

Primær færdiggørelse (Anslået)

31. december 2026

Studieafslutning (Anslået)

31. december 2026

Datoer for studieregistrering

Først indsendt

27. april 2026

Først indsendt, der opfyldte QC-kriterier

4. maj 2026

Først opslået (Faktiske)

11. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

28. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

26. maj 2026

Sidst verificeret

1. marts 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner